Pfizer Inc. buy BMO Capital Markets
Start price
02.05.24
/
50%
€25.92
Target price
02.05.25
€33.67
Performance (%)
-17.81%
End price
03.05.25
€21.30
Summary
This prediction ended on 03.05.25 with a price of €21.30. The prediction for Pfizer Inc. disappointed with a performance of -17.81%. BMO_Capital_Markets has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €1.58 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -4.521% | -4.521% | 17.985% |
| iShares Core DAX® | 3.011% | 1.442% | 22.848% |
| iShares Nasdaq 100 | 3.009% | 0.574% | 37.061% |
| iShares Nikkei 225® | 4.142% | 4.547% | 53.856% |
| iShares S&P 500 | 2.378% | 0.244% | 29.012% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $36.00 price target on the stock, up previously from $33.00.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten